Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis

Li Xu; Shanshan Chen; Haijun Cao; Zemin Feng; Chao Yang

doi:10.2478/acph-2024-0019

.blurhash-client-img { display: none !important; }

Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis

Acta Pharmaceutica

Volume 74 (2024): Issue 3 (September 2024)

By: Li Xu , Shanshan Chen , Haijun Cao , Zemin Feng and Chao Yang

Open Access

|Sep 2024

Li Xu

Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China

Shanshan Chen

Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China

Haijun Cao

Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China

Zemin Feng

Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China

Chao Yang

caoyortho_903PLA@hotmail.com

China

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/acph-2024-0019 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 405 - 422

Accepted on: Apr 2, 2024

Published on: Sep 14, 2024

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hepatocellular carcinoma,

portal vein tumor thrombosis,

transcatheter arterial chemoembolization,

sorafenib

Related subjects:

Pharmacy,

Pharmacy, other

© 2024 Li Xu, Shanshan Chen, Haijun Cao, Zemin Feng, Chao Yang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 74 (2024): Issue 3 (September 2024)